AbbVie (ABBV) Treasury Shares (2013 - 2026)

AbbVie has disclosed Treasury Shares across 14 years of filings, most recently posting $10.6 billion for Q1 2026.

• In Q1 2026, Treasury Shares rose 16.13% year-over-year to $10.6 billion; the TTM figure through Mar 2026 stood at $10.6 billion (up 16.13% YoY), while the FY2025 annual figure was $9.1 billion, up 11.52% from the prior year.
• Treasury Shares rose to $10.6 billion in Q1 2026, from $9.1 billion in the prior quarter.
• Over the last five years, Treasury Shares for ABBV reached as high as $70.8 million in Q4 2025 and fell as low as $5.0 million in Q1 2025.
• The 5-year median for Treasury Shares is $8.0 million (2022), against an average of $15.9 million.
• Annual changes were most pronounced in 2022 — Treasury Shares soared 51.99% — and 2025, when it climbed 11.52%.
• A 5-year view of Treasury Shares shows it stood at $4.6 billion in 2022, then surged by 42.21% to $6.5 billion in 2023, then advanced by 25.53% to $8.2 billion in 2024, then rose by 11.52% to $9.1 billion in 2025, then advanced by 16.02% to $10.6 billion in 2026.
• According to Business Quant data, Treasury Shares over the past three periods registered $10.6 billion, $9.1 billion, and $9.1 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.